Finance

Lists
Why is SIGHT down 2,22%?
Dive Deeper
SIGHT:EPA
Gensight Biologics SA
0,071 €
-2,22%
(-0,0016) 1D
19 қаз., 17:35:18 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SIGHT...
Open
0,07 €
High
0,07 €
Low
0,07 €
Mkt. cap
15,88 млн
Avg. vol.
1,80 млн
Volume
683,87 м.
52-wk high
0,24 €
52-wk low
0,07 €
EPS
-0,08 €
Shares outstanding
246,22 млн
No. of employees
18
Open
0,07 €
High
0,07 €
Low
0,07 €
Mkt. cap
15,88 млн
Avg. vol.
1,80 млн
Volume
683,87 м.
52-wk high
0,24 €
52-wk low
0,07 €
EPS
-0,08 €
Shares outstanding
246,22 млн
No. of employees
18
News stories
From web sources and news partners
About Gensight Biologics SA
CEO-
Employees18
Founded2012
HeadquartersПариж, Île-de-France, Франция
Sector-
Last report
2026 ж. 08 шіл.
Fiscal period
Q2 2026
- / -
Revenue / Est. (EUR)
-428,00 м. / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
302,00 м.
302,00 м.
-428,00 м.
-428,00 м.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,08 млн
1,08 млн
2,34 млн
2,34 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,36 млн
1,36 млн
1,50 млн
1,50 млн
Operating expense
2,43 млн
2,43 млн
3,84 млн
3,84 млн
Total operating expenses
2,43 млн
2,43 млн
3,84 млн
3,84 млн
Operating income
-2,13 млн
-2,13 млн
-4,27 млн
-4,27 млн
Other non operating income
436,00 м.
436,00 м.
-285,50 м.
-285,50 м.
EBT including unusual items
-2,53 млн
-2,53 млн
-5,14 млн
-5,14 млн
EBT excluding unusual items
-2,53 млн
-2,53 млн
-5,14 млн
-5,14 млн
Income tax expense
2,00 мың
2,00 мың
500,00
500,00
Effective tax rate
-0,08%
-0,08%
-0,01%
-0,01%
Other operating expenses
-
-
-
-
Net income
-2,53 млн
-2,53 млн
-5,14 млн
-5,14 млн
Net profit margin
-839,24%
-839,24%
1 199,88%
1 199,88%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-784,50 м.
-784,50 м.
-578,00 м.
-578,00 м.
Net interest expenses
-784,50 м.
-784,50 м.
-578,00 м.
-578,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,09 млн
-2,09 млн
-4,24 млн
-4,24 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары